reviewTop 1% cited

CSF markers for incipient Alzheimer's disease

The Lancet Neurology · 2003 · Vol. 2(10) · pp. 605–613

Kaj Blennow✉(University of Gothenburg)Harald Hampel(Ludwig-Maximilians-Universität München)

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Cholinesterase and Neurodegenerative DiseasesDementiaDiseaseMedicineContext (archaeology)Cognitive impairmentAcetylcholinesteraseClinical significanceAmyloid (mycology)PathologyInternal medicine

MeSH terms

Alzheimer DiseaseCholinesterase InhibitorsHumansPeptide FragmentsSensitivity and SpecificityBiomarkersAmyloid beta-PeptidesMEDLINEtau Proteins

Citations

1,290

FWCI

19.00

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Neurology · 2016 · 1,813 citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

The Lancet Neurology · 2014 · 3,256 citations

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

Archives of Neurology · 2009 · 892 citations

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

The Lancet Neurology · 2006 · 1,682 citations

PET imaging of amyloid deposition in patients with mild cognitive impairment

Neurobiology of Aging · 2007 · 724 citations

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

The Lancet Neurology · 2007 · 4,360 citations

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

Annals of Neurology · 2009 · 2,070 citations

Tau PET imaging in neurodegenerative tauopathies—still a challenge

Molecular Psychiatry · 2019 · 614 citations

References

Tangles and plaques in nondemented aging and ?preclinical? Alzheimer's disease

Annals of Neurology · 1999 · 1,682 citations

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

Archives of Neurology · 1999 · 667 citations

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Proceedings of the National Academy of Sciences · 1985 · 4,412 citations

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

Neuroscience Letters · 2001 · 449 citations

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

Neuroscience Letters · 2000 · 488 citations

Clinical diagnosis of Alzheimer's disease

Neurology · 1984 · 27,910 citations

Mild Cognitive Impairment

Archives of Neurology · 1999 · 8,888 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.